Letters

Reply: Exercise at the Extremes

Please note: Dr. Thompson has received research support from the National Institutes of Health, Genomas, Aventis, Roche, Sanofi, Regeneron, Esperion, Amarin, and Pfizer; has served as a consultant for Amgen, AstraZeneca, Regeneron, Merck, Genomas, Abbott, Pfizer, Esperion, and Sanofi; has received speaker honoraria from Merck, AstraZeneca, Regeneron, Sanofi, and Amgen; owns stock in Abbvie, Abbott Laboratories, CVS, General Electric, Johnson & Johnson, Medtronic, and JA Wiley; and has provided expert legal testimony on exercise-related cardiac events and statin myopathy. Dr. Eijsvogels is supported by a European Commission Horizon 2020 grant (Marie Sklodowska-Curie Fellowship 655502). All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.